Sarvesh Pathak

Tea in one hand, confidence in another.
#staypositive

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

The one-hour cleanliness drive (Shramdaan), led by Secretary, Shri Manoj Joshi along with Senior officers and employees of the Department of Pharmaceuticals, reinforced the Department’s commitment to institutionalising cleanliness practices, fostering a culture of hygiene and ensuring a clean and healthy workplace. The initiative also underscored the importance of active Jan Bhagidari in advancing the vision of Swachh Bharat, Viksit Bharat.

#SwachhataHiSeva2026 #SHS2026 #Swachhta_Abhiyan #DoP #pharmaceuticals

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

“To ensure there is adequate capital, there is a role for the government to provide assurance to industry to take risk. The assurance that the government is there to provide support. For resilience of supply chains, the government and industry have to work together. It cannot be only government talking or industry alone doing; it has to be a joint collaboration.”

- Shri Manoj Joshi, Secretary, Department of Pharmaceuticals, during the session on Life Sciences Manufacturing for Viksit Bharat 2047 at the Bharat Life Sciences Award & Innovation Summit at Vigyan Bhawan, New Delhi

#BharatLifeSciencesAward #ViksitBharat #IndiaLifeSciences #Pharmaceuticals

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Recognising the funding gap faced by life sciences startups, under PRIP Scheme, we have made an amendment so that up to ₹50 crores or $5 million of equity funding could be provided to start ups. We are providing an opportunity to open up a new window to fill the ‘valley of death’ in the life sciences area for startups. I hope more and more people would make use of that in PRIP as well as in the Biopharma Shakti Mission : Shri Manoj Joshi, Secretary, Department of Pharmaceuticals

#BharatLifeSciencesAward #ViksitBharat #IndiaLifeSciences #Pharmaceuticals

[Sarvesh Pathak @Sarvesh0047]

@PrinceOmarX Yes

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

“फार्मा की दिशा में हमने बहुत काम किया है। लेकिन समय की मांग है कि दुनिया की पाँच बड़ी फार्मा कंपनियों में भारतीय कंपनियों का भी नाम हो। भारत को अपनी पाँच बड़ी फार्मा कंपनियाँ दुनिया के सामने रखनी चाहिए, क्योंकि लोग हमसे उम्मीद रखते हैं।”

- स्वतंत्रता दिवस के अवसर पर लाल किले की प्राचीर से मा. प्रधानमंत्री श्री नरेंद्र मोदी का संबोधन

#Independenceday2026

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Shri Manoj Joshi, Secretary, Department of Pharmaceuticals Speaks with the Hindu Business Line

#DoP #Bulkdrugs #Pharmaceuticals

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Invest India, the National Investment Promotion and Facilitation Agency of the Government of India, signed a Memorandum of Understanding (MoU) with the Asia Pacific Medical Technology Association (APACMed), today at Bharat Mandapam, New Delhi. The MoU aims to strengthen collaboration between the Government and the global MedTech industry to facilitate investment, innovation and sustainable growth in India’s medical technology sector.

Read : https://t.co/uXh2mSph4Y

#Pharmaceuticals #Pharma #MoU

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

The Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India in collaboration with the Federation of Indian Chambers of Commerce & Industry (FICCI), is set to organise the 9th edition of India Medical Device 2026 on 7th and 8th August, 2026, at Vigyan Bhawan, New Delhi. Union Minister of Chemical and Fertilizers, Shri Jagat Prakash Nadda, will address the event on "Atmanirbhar MedTech: Accelerating India's Journey towards Viksit Bharat", outlining the Government's vision for building a globally competitive and innovation-driven medical devices ecosystem.

Read Here : https://t.co/hP3gDfUf0q

#IndiaMedicalDevice2026 #MedicalDevices #MedTech #ViksitBharat

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme- The scheme was substantially revamped after 2015. It seeks to provide quality-assured generic medicines at significantly lower prices via Jan Aushadhi Kendras (JAKs). Currently, 18,000+ Jan Aushadhi Kendras supply quality generic medicines at 50-80% lower prices. On average, about 10 to 12 lakh persons visit these Kendras daily. Subsequently, India’s middle-class benefits from significantly reduced healthcare expenses. The product portfolio of 2,110 medicines, 315 surgical items etc. improves access to treatment.Over the past 11 years, Janaushadhi products have helped save ₹40,000 crore by reducing out-of-pocket medicine expenses for families.

Read Here : https://t.co/H1kWqoJ0mx

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

The Government remains fully engaged in facilitating supplies on a case-by-case basis, with active support from the Ministry of Petroleum and Natural Gas, to ensure uninterrupted production of essential medicines : Shri Satyaprakash T L, Joint Secretary, Department of Pharmaceuticals

@PIB_India @PIBHindi @DDNewslive @mygovindia @airnewsalerts

#EnergySecurity

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Bulk Drug Parks approved in Gujarat, Himachal Pradesh and Andhra Pradesh, with ₹1,000 crore central grant each, are progressing to strengthen domestic manufacturing infrastructure.
#BulkDrugParks #IndustrialGrowth

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Department of Pharmaceuticals observed #RashtriyaEktaDiwas 2025, commemorating the 150th birth anniversary of Sardar Vallabhbhai Patel.
Secretary Shri Amit Agrawal led the #UnityPledge with officers, reaffirming our collective resolve towards national unity and integrity.

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

A clean workplace inspires productivity! ✨
As part of #SpecialCampaign5_0, Department of Pharmaceuticals undertook an intensive cleaning activity covering corridors, offices & meeting halls — fostering a culture of hygiene and care. 🌿🧽

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

PRIP Applications LIVE NOW!
REGISTER via Entity Locker - more details to follow!

✅ Accepting applications across New medicines, Complex generics & Biosimilars, and Novel medical devices
✅ With higher funding for projects addressing areas of India’s public health concerns with lower market potential

#PRIP #InnovateInIndia #Pharma #MedTech #StartupIndia #MSME

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Call for applications under PRIP Scheme now LIVE!

A landmark policy for supporting ~₹11,000 crore worth industry & startup research and innovation projects in Pharma–MedTech

PRIP scheme amended to enhance impact:
💰 Higher support for early-stage projects
🌍 Flexible pathways (academic collab, TRLs & more)
🧪 Idea-to-Market: from early-stage to advanced TRLs
🛡 Focus on public health priorities on India

Apply now on the PRIP Portal

#PRIP #InnovateInIndia #Pharma #MedTech #StartupIndia #MSME

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Excellence continues! 🎉

All 7 NIPERs shine in #NIRF2025, securing spots in the Top 30 for #Pharmaceuticals Education.

#BrandNIPER #NIRF2025

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

#NextGenGST

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

#indiamedtechexpo2025

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

💊 GST on essential medicines & medical devices reduced from 12% ➡ 5%/Nil.
👉 Cheaper long-term treatment for chronic illnesses
👉 Affordable diagnostics & vision care
👉 Boosts India as the Pharmacy of the World 🌍
#HealthcareForAll #GST

�� GST on Medical Devices & Equipment reduced from 12% ➡ 5% (oxygen, bandages, diagnostic kits, glucometers, etc.)
✔ Cheaper care for hospitals & clinics
✔ Wider access to modern diagnostics in Tier-2/3 towns
Strengthening quality healthcare across Bharat. 🇮🇳
#AffordableHealthcare #GST

@PMOIndia
@JPNadda
@AnupriyaSPatel
@PIB_India
@PibMinistry

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

#NextGenGST